75 Trending Stocks

Fri, Jan 15, 2021

Adamis Pharmaceuticals Corp

ADMP 0.78
0.03 (3.7%)

Open: 0.81 High: 0.84 Low: 0.75

9 x 0.78 = 7.02
x $0.78 =

NASDAQ: ADMP $70 Million Small-Cap. Health Care Sector. Drug Manufacturers Industry. 5 Year Return 81%. 1 Year Return 0%. 2021 YTD Return 44%. Since Earnings 8%.

ST

External Links

Charts

image
image

52WL $0.27

The 52 Week Low is $0.27 set on Wed, Mar 18, 2020.

52WH $1.51

The 52 Week High is $1.51 set on Wed, Jul 29, 2020.

ATH $18.53

The All-Time High is $18.53 set on Thu, Nov 8, 2012.

52 Week Range

$0.27
$1.51
Mar 18, 2020
Jul 29, 2020

Earnings

-0.15

Earnings Per Share

0.00

Price To Earnings Ratio


Q2 Earnings for Apr, May & Jun

Thu, Aug 20, 2020

Since Q2 Earnings Report

ADMP 15.2%


Q3 Earnings for Jul, Aug & Sep

Mon, Nov 9, 2020

Since Q3 Earnings Report

ADMP 8.3%

Dividends

0.00

Dividend Yield

0.00

Dividend Rate

--

Ex-Dividend Date

--

Dividend Payment Date

--

Dividend Frequency

0

Dividend History

Profile

Adamis Pharmaceuticals Corp trades on the NASDAQ. ADMP's market cap is 70.00 Million.

Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company. It is focused on developing and commercializing products in various therapeutic areas, including respiratory disease, allergy, and opioid overdose. Its SYMJEPI (epinephrine) Injection products are used in the emergency treatment of acute allergic reactions, including anaphylaxis. Adamis is developing additional products, including a naloxone injection product candidate, ZIMHI, for the treatment of opioid overdose, and other products for the treatment of asthma and COPD. Its subsidiary compounds sterile prescription drugs, and certain nonsterile drugs for use by hospitals, clinics, and surgery centers throughout the U.S.

Website

Related Channels

Free Channels & more...

For Starters

Account Channels

Track your portfolio and more.